BNP Paribas Exane initiated coverage on shares of Vylor (NYSE:VYLR – Get Free Report) in a report released on Wednesday, Marketbeat reports. The brokerage set a “neutral” rating and a $75.00 price target on the stock. BNP Paribas Exane’s price target suggests a potential upside of 1.34% from the company’s previous close.
Other research analysts also recently issued research reports about the stock. Weiss Ratings assumed coverage on shares of Vylor in a research report on Friday, October 2nd. They set a “sell (d+)” rating on the stock. Oppenheimer assumed coverage on shares of Vylor in a research report on Tuesday, October 6th. They issued an “outperform” rating and a $82.00 price objective for the company. Bank of America started coverage on shares of Vylor in a research note on Monday, October 5th. They issued a “buy” rating and a $78.00 target price for the company. The Goldman Sachs Group assumed coverage on shares of Vylor in a research report on Thursday, October 8th. They set a “buy” rating and a $87.00 target price on the stock. Finally, Royal Bank Of Canada began coverage on Vylor in a research report on Friday, October 2nd. They issued an “outperform” rating and a $85.00 price objective on the stock. Three investment analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $82.67.
Read Our Latest Stock Analysis on Vylor
Vylor Price Performance
Vylor Company Profile
Vylor Inc is a seed and genetics company. It develops and supplies germplasm for farmers to improve crop health and produce higher yields. Vylor Inc is based in JOHNSTON, Iowa.
Further Reading
- Five stocks we like better than Vylor
- Solaris Rides the AI Boom as Risks Mount
- Big Banks Report Strong Earnings—So Why Are Shares Falling?
- Mortgage Rates Squeeze FHA Buyers: 3 Housing Stocks to Watch
- UnitedHealth Beats on Earnings, But Investors Question Growth Path
Receive News & Ratings for Vylor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vylor and related companies with MarketBeat.com's FREE daily email newsletter.
